Gua Sha Alleviates Radiculitis-Induced Pain Via HIF-1α-Mediated Metabolic Reprogramming Pathway in Rats

被引:0
|
作者
Ge, Haotian [1 ]
Yan, Shuxia [1 ]
Yin, Mingwan [1 ]
Gao, Yujie [1 ]
Wang, Jiayi [1 ]
Wang, Qin [1 ,2 ]
Xu, Guihua [1 ]
Yang, Min [1 ]
机构
[1] Nanjing Univ Chinese Med, Sch Nursing, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, TCM Nursing Intervent Lab Chron Dis, Nanjing, Peoples R China
关键词
Gua Sha; HIF-1; alpha; inflammation; metabolic reprogramming; radiculitis-induced pain; HYPOXIA; EXPRESSION; YC-1; ACCUMULATION; ADAPTATION; MECHANISMS; CELLS;
D O I
10.1155/prm/9923147
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Radiculitis-induced pain (RIP) results from dorsal root ganglion (DRG) sensitization due to inflammation. Hypoxia-inducible factor 1-alpha (HIF-1 alpha) is linked to inflammatory responses through metabolic changes, but its role in RIP is not well understood. Gua Sha therapy has been shown to reduce inflammation and neural damage from lumbar disc herniation (LDH). This study investigates whether HIF-1 alpha-mediated metabolic reprogramming contributes to the pain-relieving effects of Gua Sha in RIP.Methods: Male SD rats were subjected to LDH surgery and divided into six groups: sham, model, sham Gua Sha, Gua Sha, Gua Sha + DMOG, and Gua Sha + YC-1. Gua Sha was applied 5 days postsurgery, every other day for three sessions per course, totaling three courses. Changes in paw withdrawal threshold (PWT) and latency (PWL) were monitored, along with blood flow in the rats' backs. Levels of IL-1 beta, TNF-alpha, and NF-kappa B were assessed in serum and DRG tissue. Pathological changes and hypoxia in DRG tissues were observed using hematoxylin-eosin staining and immunofluorescence. Western blotting and qPCR measured HIF-1 alpha, GLUT1, PFKM, and PDK1 expression, while lactic acid and ATP levels in DRG tissue were also evaluated.Results: Gua Sha increased PWT and PWL, reduced serum and DRG inflammatory factors, improved back microcirculation, alleviated DRG hypoxia, and decreased HIF-1 alpha and related signaling factors. It also lowered lactic acid and raised ATP levels. DMOG, a HIF-1 alpha activator, reversed these effects. HIF-1 alpha activation did not affect serum inflammatory factors but partially improved PWT. Inhibition of HIF-1 alpha with YC-1 did not significantly differ from Gua Sha alone.Conclusion: HIF-1 alpha-mediated metabolic reprogramming is a pathogenic mechanism in RIP. Gua Sha alleviates RIP by enhancing microcirculation, improving DRG hypoxia, inhibiting HIF-1 alpha-mediated reprogramming, and reducing DRG sensitization and inflammation. This study provides insights into the mechanisms of Gua Sha's therapeutic effects in RIP.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Hypoxia augments NaHS-induced ANP secretion via KATP channel, HIF-1α and PPAR-γ pathway
    Yu, Lamei
    Li, Weijian
    Park, Byung Mun
    Lee, Gi-Ja
    Kim, Suhn Hee
    PEPTIDES, 2019, 121
  • [22] Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/HIF-1α signaling pathway in the rat spinal cord
    Liu, Qingying
    Lu, Zhongyuan
    Ren, Huan
    Fu, Lijun
    Wang, Yueliang
    Bu, Huilian
    Ma, Minyu
    Ma, Letian
    Huang, Chen
    Wang, Jian
    Zang, Weidong
    Cao, Jing
    Fan, Xiaochong
    JOURNAL OF BONE ONCOLOGY, 2023, 42
  • [23] Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway
    Abdel-latif, Rania G.
    Rifaai, Rehab A.
    Amin, Entesar F.
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (05) : 514 - 525
  • [24] ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer
    Dong, Shuohui
    Liang, Shuo
    Cheng, Zhiqiang
    Zhang, Xiang
    Luo, Li
    Li, Linchuan
    Zhang, Wenjie
    Li, Songhan
    Xu, Qian
    Zhong, Mingwei
    Zhu, Jiankang
    Zhang, Guangyong
    Hu, Sanyuan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [25] HIF-1α is required for disturbed flow-induced metabolic reprogramming in human and porcine vascular endothelium
    Wu, David
    Huang, Ru-Ting
    Hamanaka, Robert B.
    Krause, Matt
    Oh, Myung-Jin
    Kuo, Cheng-Hsiang
    Nigdelioglu, Recep
    Meliton, Angelo Y.
    Witt, Leah
    Dai, Guohao
    Civelek, Mete
    Prabhakar, Nanduri R.
    Fang, Yun
    Mutlu, Gkhan M.
    ELIFE, 2017, 6
  • [26] Hydroxysafflor Yellow A Alleviates Ischemic Stroke in Rats via HIF-1α, BNIP3, and Notch1-Mediated Inhibition of Autophagy
    Zhang, Yuliang
    Liu, Yi
    Cui, Qian
    Fu, Zitong
    Yu, Haoyu
    Liu, Ao
    Liu, Jingjing
    Qin, Xiude
    Ge, Shaoqin
    Zhang, Guowei
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2022, 50 (03): : 799 - 815
  • [27] IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
    Shigeta, Keisuke
    Hasegawa, Masanori
    Hishiki, Takako
    Naito, Yoshiko
    Baba, Yuto
    Mikami, Shuji
    Matsumoto, Kazuhiro
    Mizuno, Ryuichi
    Miyajima, Akira
    Kikuchi, Eiji
    Saya, Hideyuki
    Kosaka, Takeo
    Oya, Mototsugu
    EMBO JOURNAL, 2023, 42 (04)
  • [28] Drp1-mediated mitochondrial fission promotes pulmonary fibrosis progression through the regulation of lipid metabolic reprogramming by ROS/HIF-1α
    Tong, Zhongkai
    Du, Xuekui
    Zhou, Ying
    Jing, Fangxue
    Ma, JiangPo
    Feng, Yingying
    Lou, Saiyun
    Wang, Qiong
    Dong, Zhaoxing
    CELLULAR SIGNALLING, 2024, 117
  • [29] LncRNA SNHG1 alleviates OGD induced injury in BMEC via miR-338/HIF-1α axis
    Yang, Xia
    Zi, Xiao-Hong
    BRAIN RESEARCH, 2019, 1714 : 174 - 181
  • [30] Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF-1α/VEGF via Activating Nrf2 Antioxidant Pathway
    Liu, Chang
    Cheng, Tianwei
    Wang, Yufei
    Li, Guangru
    Wang, Yachen
    Tian, Wencong
    Feng, Lifeng
    Zhang, Shengzheng
    Xu, Yang
    Gao, Yang
    Li, Jing
    Liu, Jie
    Cui, Jianlin
    Yan, Jie
    Cao, Lei
    Pan, Zhongjie
    Qi, Zhi
    Yang, Liang
    MOLECULAR NUTRITION & FOOD RESEARCH, 2024, 68 (04)